Related Experiment Video
Updated: Mar 2, 2026
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
1.6K
Diabetes Mellitus and Heart Failure.
Michael Lehrke1, Nikolaus Marx1
1Department of Internal Medicine I, University Hospital Aachen, Germany.
The American Journal of Medicine
|May 21, 2017
Summary
Heart failure is common and has a worse prognosis in patients with diabetes. Sodium glucose cotransporter 2 inhibitors like empagliflozin show promise in reducing heart failure hospitalizations for these individuals.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- Heart failure (HF) prevalence is high in diabetes patients, with a poorer prognosis compared to non-diabetic individuals.
- Diabetic cardiomyopathy contributes to HF, independent of coronary artery disease and traditional risk factors.
- Emerging evidence highlights complex pathophysiological links between diabetes and cardiac dysfunction.
Purpose of the Study:
- To review current data on the prevalence and prognosis of heart failure in patients with diabetes.
- To explore the underlying pathophysiological mechanisms of diabetic heart disease.
- To summarize therapeutic strategies for managing heart failure in the context of diabetes.
Main Methods:
- Review of epidemiologic and clinical data from the past two decades.
- Analysis of experimental data on cardiac function in diabetes.
- Evaluation of clinical trial results, including the impact of empagliflozin.
Main Results:
- High prevalence and worse outcomes of heart failure in patients with diabetes.
- Identification of multiple mechanisms contributing to diabetic cardiomyopathy.
- Demonstration that sodium glucose cotransporter 2 inhibitors (e.g., empagliflozin) reduce heart failure hospitalizations in high-risk type 2 diabetes patients.
Conclusions:
- Diabetes significantly worsens heart failure outcomes.
- Understanding the pathophysiology is crucial for targeted therapies.
- Sodium glucose cotransporter 2 inhibitors represent a promising therapeutic strategy for reducing heart failure burden in diabetic populations.
Related Concept Videos
01:27Heart Failure I: Introduction
1.1K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.1K
01:17Pathophysiology of Heart Failure
4.2K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K
01:22Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
01:29Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
486
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
486
01:22Diabetes Mellitus: Type 2 and Gestational
5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K